Study ID: C38072-AS-30027 | 2015-001580-39

Study Title

An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils

Teva Identifier

C38072-AS-30027 | 2015-001580-39

ClinicalTrials.gov Identifier

NCT02501629

Study Status

Completed

Trial Condition(s)

Asthma | Elevated Blood Eosinophils | Oral Corticosteroid Dependence

Interventions

Drug: Reslizumab | Drug: Placebo | Drug: Non-Oral Corticosteroid (non-OCS) Asthma Medication | Drug: Oral Corticosteroid (OCS)

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

September 29, 2015 - December 4, 2017

Phase

Phase 3

Study Type

Interventional